{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:49:55Z","timestamp":1761518995054},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s10147-011-0207-5","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T19:18:54Z","timestamp":1299007134000},"page":"473-481","source":"Crossref","is-referenced-by-count":11,"title":["Factors influencing the outcome of breast cancer patients with 10 or more metastasized axillary lymph nodes"],"prefix":"10.1007","volume":"16","author":[{"given":"Jun Sang","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Seok","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seho","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaseung","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong-Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyong Sik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"key":"207_CR1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3816\/CBC.2005.n.043","volume":"6","author":"GN Hortobagyi","year":"2005","unstructured":"Hortobagyi GN, de la Garza Salazar J, Pritchard K et al (2005) The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 6:391\u2013401","journal-title":"Clin Breast Cancer"},{"key":"207_CR2","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jnci\/djm059","volume":"99","author":"AG Glass","year":"2007","unstructured":"Glass AG, Lacey JV Jr, Carreon JD et al (2007) Breast cancer incidence, 1980\u20132006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99:1152\u20131161","journal-title":"J Natl Cancer Inst"},{"key":"207_CR3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semradonc.2009.05.003","volume":"19","author":"LA Newman","year":"2009","unstructured":"Newman LA (2009) Epidemiology of locally advanced breast cancer. Semin Radiat Oncol 19:195\u2013203","journal-title":"Semin Radiat Oncol"},{"key":"207_CR4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00000421-198710000-00005","volume":"10","author":"SE Jones","year":"1987","unstructured":"Jones SE, Moon TE, Bonadonna G et al (1987) Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base. Am J Clin Oncol 10:387\u2013395","journal-title":"Am J Clin Oncol"},{"key":"207_CR5","doi-asserted-by":"crossref","unstructured":"Basaran G, Devrim C, Caglar HB et al (2010) Clinical outcome of breast cancer patients with N3a (>\/=10 positive lymph nodes) disease: has it changed over years? Med Oncol (in press). doi: 10.1007\/s12032-010-9516-1","DOI":"10.1007\/s12032-010-9516-1"},{"key":"207_CR6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0039-6109(03)00034-3","volume":"83","author":"SE Singletary","year":"2003","unstructured":"Singletary SE, Allred C, Ashley P et al (2003) Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am 83:803\u2013819","journal-title":"Surg Clin North Am"},{"key":"207_CR7","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","volume":"347","author":"MJ Vijver van de","year":"2002","unstructured":"van de Vijver MJ, He YD, van\u2019t Veer LJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999\u20132009","journal-title":"N Engl J Med"},{"key":"207_CR8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/cncr.21182","volume":"104","author":"AJ Montero","year":"2005","unstructured":"Montero AJ, Rouzier R, Lluch A et al (2005) The natural history of breast carcinoma in patients with > or =10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study. Cancer 104:229\u2013235","journal-title":"Cancer"},{"key":"207_CR9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1245\/s10434-007-9558-6","volume":"15","author":"N Duraker","year":"2008","unstructured":"Duraker N, Caynak ZC, Bati B (2008) Is there any prognostically different subgroup among patients with stage IIIC (any TN3M0) breast carcinoma? Ann Surg Oncol 15:430\u2013437","journal-title":"Ann Surg Oncol"},{"key":"207_CR10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/1097-0142(19920115)69:2<448::AID-CNCR2820690229>3.0.CO;2-K","volume":"69","author":"AU Buzdar","year":"1992","unstructured":"Buzdar AU, Kau SW, Hortobagyi GN et al (1992) Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy. Cancer 69:448\u2013452","journal-title":"Cancer"},{"key":"207_CR11","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/BF02388136","volume":"27","author":"A Tsuchiya","year":"1997","unstructured":"Tsuchiya A, Kanno M, Abe R (1997) The impact of lymph node metastases on the survival of breast cancer patients with ten or more positive lymph nodes. Surg Today 27:902\u2013906","journal-title":"Surg Today"},{"key":"207_CR12","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.1998.16.5.1655","volume":"16","author":"SG Diab","year":"1998","unstructured":"Diab SG, Hilsenbeck SG, de Moor C et al (1998) Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy. J Clin Oncol 16:1655\u20131660","journal-title":"J Clin Oncol"},{"key":"207_CR13","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0959-8049(01)00090-9","volume":"37","author":"C Schmoor","year":"2001","unstructured":"Schmoor C, Sauerbrei W, Bastert G et al (2001) Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF. Eur J Cancer 37:1123\u20131131","journal-title":"Eur J Cancer"},{"key":"207_CR14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ijrobp.2006.12.027","volume":"68","author":"FB Geara","year":"2007","unstructured":"Geara FB, Nasr E, Tucker SL et al (2007) Breast cancer patients with 10 or more involved axillary lymph nodes treated by multimodality therapy: influence of clinical presentation on outcome. Int J Radiat Oncol Biol Phys 68:364\u2013369","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"207_CR15","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/1097-0142(19800615)45:12<2917::AID-CNCR2820451203>3.0.CO;2-M","volume":"45","author":"T Nemoto","year":"1980","unstructured":"Nemoto T, Vana J, Bedwani RN et al (1980) Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45:2917\u20132924","journal-title":"Cancer"},{"key":"207_CR16","first-page":"309","volume":"159","author":"RE Wilson","year":"1984","unstructured":"Wilson RE, Donegan WL, Mettlin C et al (1984) The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet 159:309\u2013318","journal-title":"Surg Gynecol Obstet"},{"key":"207_CR17","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9610(98)00253-0","volume":"176","author":"HM Kuerer","year":"1998","unstructured":"Kuerer HM, Newman LA, Buzdar AU et al (1998) Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg 176:502\u2013509","journal-title":"Am J Surg"},{"key":"207_CR18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/ejso.1999.0737","volume":"26","author":"E Yildirim","year":"2000","unstructured":"Yildirim E, Semerci E, Berberoglu U (2000) The analysis of prognostic factors in stage III-B non-inflammatory breast cancer. Eur J Surg Oncol 26:34\u201338","journal-title":"Eur J Surg Oncol"},{"key":"207_CR19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2325\/jbcs.14.381","volume":"14","author":"M Ito","year":"2007","unstructured":"Ito M, Moriya T, Ishida T et al (2007) Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer. Breast Cancer 14:381\u2013387","journal-title":"Breast Cancer"},{"key":"207_CR20","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/annonc\/mdi326","volume":"16","author":"A Goldhirsch","year":"2005","unstructured":"Goldhirsch A, Glick JH, Gelber RD et al (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16:1569\u20131583","journal-title":"Ann Oncol"},{"key":"207_CR21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.sla.0000133355.48672.22","volume":"240","author":"SF Schoppmann","year":"2004","unstructured":"Schoppmann SF, Bayer G, Aumayr K et al (2004) Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240:306\u2013312","journal-title":"Ann Surg"},{"key":"207_CR22","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1200\/JCO.20.6.1456","volume":"20","author":"IC Smith","year":"2002","unstructured":"Smith IC, Heys SD, Hutcheon AW et al (2002) Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol 20:1456\u20131466","journal-title":"J Clin Oncol"},{"key":"207_CR23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/jnci\/djn085","volume":"100","author":"G Minckwitz von","year":"2008","unstructured":"von Minckwitz G, Kummel S, Vogel P et al (2008) Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial. J Natl Cancer Inst 100:542\u2013551","journal-title":"J Natl Cancer Inst"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-011-0207-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-011-0207-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-011-0207-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T22:26:05Z","timestamp":1560032765000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-011-0207-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["207"],"URL":"https:\/\/doi.org\/10.1007\/s10147-011-0207-5","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}